Skip to content

Author

M. deBettencourt

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Real-World Outcomes in the Evolving Second-Line Systemic Therapy Landscape in Hepatocellular Carcinoma: A Single-Institution Experience.

OBJECTIVES Historically, few treatments existed for hepatocellular carcinoma (HCC) until sorafenib's approval in 2007. Meaningful treatment advances included approval of atezolizumab plus bevacizumab in 2020 and tremelimumab plus durvalumab in 2022. However, optimal second-line systemic therapy and outcomes after curre...

M. deBettencourt, Kayéromi Gomez, Nina Undevia Yedavalli · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.